GlassScriptPhysician profile
Joseph M Stamm
NPI 1295704559
$9,505.51
in general payments reported to CMS, 2019-2025
10 companies · $4,545 in 2025
The $4,545 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,431 · 2020: $508 · 2021: $202 · 2022: $555 · 2023: $1,077 · 2024: $1,188 · 2025: $4,545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,100 · Food and Beverage: $1,536 · Travel and Lodging: $1,124 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $400 · Gift: $350 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,100.00 |
| Food and Beverage | $1,536.07 |
| Travel and Lodging | $1,123.99 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $400.00 |
| Gift | $350.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,309.05 | 2023-2025 | Xiidra, Infuse, Miebo |
| Alcon Vision LLC | $2,796.28 | 2019-2025 | Air Optix, Precision7 |
| Johnson & Johnson Vision Care, INC. | $1,682.04 | 2019-2025 | Acuvue |
| Coopervision INC. | $728.36 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Visionary Optics LLC | $350.00 | 2023 | |
| Glaukos Corporation | $260.85 | 2023-2024 | Ce-Marked Kxla System, Kxl System (Not Refurbished) |
| Oyster Point Pharma, INC. | $241.67 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $101.09 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.67 | 2019 | |
| Biotissue Holdings INC. | $17.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Stamm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.